Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Patient perspective on cancer and pregnancy (Italian)

Cancer and Pregnancy 2012

Published: 9 May 2012

Views: 6995

Rating:

Save

Silvia Formichetti - Breast Cancer Survivor

Silvia Formichetti describes her experience with the discovery of a tumour during pregnancy. In 2009, she was 6 months pregnant and waited until 7 months to deliver. She was operated on immediately thereafter and now undergoes normal follow up.

The interview was conducted in Italian.

The Cancer in Pregnancy meeting 2012 is endorsed by ESGO

Related Videos

Choosing Wisely for young women with breast cancer: Medical therapy

Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India

Choosing Wisely for young women with breast cancer: Medical therapy ( Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India )

Breastfeeding after breast cancer is safe

Dr Eva Blondeaux - Ospedale San Martino, Genova, Italy

Breastfeeding after breast cancer is safe ( Dr Eva Blondeaux - Ospedale San Martino, Genova, Italy )

Intervention of osteoclastogenesis that occurs in breast cancer and multiple...

Dr Gregg Fields - Florida Atlantic University, Florida, USA

Intervention of osteoclastogenesis that occurs in breast cancer and multiple myeloma ( Dr Gregg Fields - Florida Atlantic University, Florida, USA )

Trastuzumab deruxtecan significantly improves PFS In breast cancer patients...

Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy

Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated with endocrine therapy ( Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy )

Quality of life and patient satisfaction of Filipinos after breast conservation...

Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines

Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy ( Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines )

Inavolisib, palbociclib, fulvestrant combo shows sustained benefit beyond...

Dr Dejan Juric - Massachusetts General Hospital, Boston, USA

Inavolisib, palbociclib, fulvestrant combo shows sustained benefit beyond disease progression in HER2‑negative metastatic breast cancer ( Dr Dejan Juric - Massachusetts General Hospital, Boston, USA )

Low-dose olanzapine after highly emetogenic chemotherapy can be the new...

Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours ( Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India )

Supporting breast cancer patients in Vietnam

Ms Thu Ha Hoang - Founder, Kien Cuong Cancer Support Club, Vietnam

Supporting breast cancer patients in Vietnam ( Ms Thu Ha Hoang - Founder, Kien Cuong Cancer Support Club, Vietnam )

Updates on HR-positive HER2-negative breast cancer

Dr Mariana Chavez - MD Anderson Cancer Center, Houston, USA

Updates on HR-positive HER2-negative breast cancer ( Dr Mariana Chavez - MD Anderson Cancer Center, Houston, USA )

More from ecancer